ZYVERSA THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Stock Issued During Period, Shares, New Issues of 114 shares as of 2019-04-18, per its 10-K filed 2025-03-27.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2025-03-27
- 2019-04-18: Stock Issued During Period, Shares, New Issues 114.00 shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2019-04-18 | 114.00 shares 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |